Performing a preliminary hazard analysis applied to administration of injectable drugs to infants.

Nadia HfaiedhSofiane KabicheCatherine DelescluseIssa-Bella BaldeSophie MerlinSandra CarretLoïc de PontualJean-Eudes FontanJoel Schlatter

Published in: Journal of evaluation in clinical practice (2017)

The PHA can be used as an aid in the prioritization of corrective actions and the implementation of control measures to reduce risk. The PHA is a complement of the a posteriori risk management already exists.

Keyphrases

primary care
quality improvement
hyaluronic acid
drug induced